Research progress in intelligent control of intrapartum oxytocin (unrevised version)

Abstract

With the development of precision medicine and artificial intelligence, the infusion of many drugs has been intelligently controlled according to patients’ conditions. However, the infusion of oxytocin (OT) still relies on medical staff responsible for implementing artificial regulation based on observation of fetal electronic monitoring and other maternal and fetal conditions. In this review, we discussed recent trends in intelligent infusion systems, the development status and dilemma of intelligent control of OT infusion, the drug intelligent feedback control system principle, and current risks and challenges to further promote obstetric informatization.

Keywords:

• Oxytocin
• intelligent infusion system
• research progress

Disclosure statement

No potential conflict of interest was reported by the authors.

Data availability

The datasets used in the current study are available from the corresponding author upon reasonable request.

Additional information

Funding

This review was supported by the Science and Technology Project of Deyang City (2022SCZ140).